AXIM Biotech Announces Successful Proprietary Extraction Method for Pure Cannabinoid Molecules | CashCropToday
0 Shares 156 Views

AXIM Biotech Announces Successful Proprietary Extraction Method for Pure Cannabinoid Molecules

February 28, 2018
156 Views

On February 27, 2018, AXIM® Biotechnologies (OTC:AXIM) announced the innovation of a new method to extract and micro-encapsulate cannabinoid molecules for a variety of pharmaceutical delivery formats from medicinal cannabis. The breakthrough makes AXIM the only company in the world with the ability to harness the proprietary procedure and provide Active Pharmaceutical Ingredients (“APIs”) of like purity from naturally extracted sources.

The secretive process, which was developed and tested in the Netherlands under strict regulatory guidelines, involves the growth of selected cannabis plants followed by extraction of the cannabinoid molecules from cannabis flowers in a process that employs just two steps in order to achieve an average of more than 99% purity (unlike traditional methods that include toxic solvents and multiple steps to produce the final extract or synthesize an API). AXIM’s newly developed microencapsulation method is then applied to the cannabinoids, protecting those from oxidation and degradation, while preserving its effectiveness. Finally, AXIM’s microencapsulated cannabinoids are manufactured into pharmaceutical products within different delivery formats.

AXIM® Biotechnologies, Inc. (AXIM) focuses on the research, development and production of cannabinoid-based pharmaceutical, nutraceutical and cosmetic products. The company’s flagship products currently include CanChew+®, a CBD-based controlled release chewing gum, and MedChew Rx®, a combination CBD/THC gum which both provide for the treatment of pain and spasticity associated with multiple conditions.

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
270 views
Market Watch
270 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
194 views
Global
194 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
190 views
Manufacturing
190 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: